Sarcoma  >>  linsitinib (ASP7487)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
linsitinib (ASP7487) / Sling Therap
NCT01560260: Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Completed
2
20
US
Laboratory Biomarker Analysis, Linsitinib, IGF-1R inhibitor OSI-906, OSI-906, OSI-906AA, Pharmacological Study
National Cancer Institute (NCI)
Carney Complex, Chondrosarcoma, Gastrointestinal Stromal Tumor, Paraganglioma
10/15
10/15
LINES, NCT02546544 / 2012-000616-28: Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma

Completed
2
16
Europe
Linsitinib, OSI-906, ASP7487
University of Oxford, European Organisation for Research and Treatment of Cancer - EORTC, European Commission, Astellas Pharma Inc, Oxford University Hospitals NHS Trust
Relapsed Ewing Sarcoma, Refractory Ewing Sarcoma
07/16
07/16

Download Options